
Vericel Corporation VCEL
$ 35.48
0.21%
Quarterly report 2026-Q1
added 05-07-2026
Vericel Corporation P/S Ratio 2011-2026 | VCEL
Annual P/S Ratio Vericel Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.82 | 10.2 | 11.1 | 8.72 | 10.6 | 15 | 6.3 | 7.48 | 3.84 | 1.08 | 0.98 | 1.27 | 562 | 2.61 K | 4.31 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.31 K | 0.98 | 505 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
2.13 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Celyad Oncology SA
CYAD
|
21.3 K | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
30.3 | - | - | $ 344 M | ||
|
IMV
IMV
|
48.2 | - | - | $ 13.1 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 91.4 | 1.15 % | $ 22.1 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.66 | 2.21 % | $ 442 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
2.54 | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
2.7 | $ 2.65 | -2.22 % | $ 248 M | ||
|
Anika Therapeutics
ANIK
|
1.9 | $ 15.09 | -0.33 % | $ 216 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
41.6 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
11.9 | $ 3.4 | 2.41 % | $ 5.6 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.6 | 5.63 % | $ 187 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 20.95 | 2.34 % | $ 2.67 B | ||
|
Ampio Pharmaceuticals
AMPE
|
236 | - | -11.43 % | $ 502 K | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M |